Primary cutaneous plasmacytoma after rejection of a transplanted kidney: Case report and review of the literature

International Journal of Hematology

Volumn 80, Issue 4, 2004, Pages 361-364

  Tessari, Gianpaolo ^a,b   Fabbian, Fabio ^a   Colato, Chiara ^a   Benedetti, Fabio ^b   Franchini, Massimo ^b   Ortalda, Vittorio ^a   Cavallini, Lucia ^a   Barba, Annalisa ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Dialysis; Plasmacytoma; Posttransplantation lymphoproliferative disorders; Uremia

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; FOLLOW UP; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MALE; PLASMA CELL; PLASMACYTOMA; SKIN BIOPSY; SKIN LYMPHOMA; SYMPTOM; TREATMENT OUTCOME; UREMIA; VIRUS INFECTION;

GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMACYTOMA; SKIN NEOPLASMS;

EID: 9444229422     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.E0406     Document Type: Article

References (35)

1. Penn I. Some problems with posttransplant lymphoproliferative disease. Transplantation. 2000;69:705-706.
2. Fischer T, Miller M, Bott-Silverman C, Lichtin A. Posttransplant lymphoproliferative disease after cardiac transplantation. Transplantation. 1996;62:1687-1690.
3. Swerdlow AJ, Higgins CD, Hunt BJ, et al. Risk of lymphoid neoplasia after cardiothoracic transplantation. Transplantation. 2000; 69:897-904.
4. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 1991;337:320-322.
5. Tuting T, Bork K. Primary plasmacytoma of the skin. J Am Acad Dermatol. 1996;34:386-390.
6. Muscardin L, Pulsoni A, Cerroni L. Primary cutaneous plasmacytoma: report of a case with review of the literature. J Am Acad Dermatol. 2000;43:962-965.
7. Wong KF, Chan JKC, Li LPK, Yau TK. Primary cutaneous plasmacytoma: report of two cases and review of the literature. Am J Dermatopathol. 1994;16:392-397.
8. Kazakov DV, Belousova IE, Muller B, et al. Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long-term follow-up and review of the literature. J Cutan Pathol. 2002; 29:244-248.
9. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93-99.
10. Bierkland SA, Lokkegaard H, Storm HH. Cancer in patients on dialysis and after renal transplantation. Lancet. 2000;355:1886-1887.
11. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342:1514-1516.
12. Hanto DW, Simmons RI. Lymphoproliferative diseases in immunosuppressed patients. In: Morris PJ, Tinley NL, eds. Progress in Transplantation. Edinburgh, UK: Churchill Livingstone; 1984:170-192.
13. Penn I. Letter to the editor. Am J Kidney Dis. 1988;11:201.
14. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000;23:101-112.
15. York LJ, Qualtiere LF. Cyclosporine abrogates virus-specific T cell control of EBV-induced B cell lymphoproliferation. Viral Immunol. 1990;3:127-136.
16. Zanazzi M, Bertoni E, Di Maria L, Rosati A, Tosi B, Salvadori M. Malignancies in renal transplant patients: etiopathogenetic, epidemiological and prevention aspects. Ital J Nephrol. 1999;16:564-575.
17. Dotti G, Fiocchi R, Motta T, et al. Epstein Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney and liver transplant. Transplantation. 2000;69:827-833.
18. Joseph G, Barker RL, Yuan B, Martin A, Medeiros J, Peiper SC. Post-transplantation plasma cell dyscrasias. Cancer. 1994;7:1959-1964.
19. Rees L, Amlot PL. Disappearance of an Epstein Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression. Lancet. 1998;352:789.
20. Nalesnik MA, Starzl TE. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci. 1994;4:61-79.
21. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mol Pathol. 1999;12:200-217.
22. Leigh BR, Larkin EC, Scotte Doggett RL. Solitary extramedullary plasmacytoma five years after successful cardiac transplantation. Am J Clin Oncol. 1997;20:467-470.
23. Melato M, Paladini G. Multiple myeloma following reactivated Epstein Barr virus infection in a renal transplant recipient. Haematologica. 1986;71:241-243.
24. Whittam LR, Coleman R, MacDonald DM. Plasma cell tumour in a renal transplant recipient. Clin Exp Dermatol. 1996;21:367-369.
25. Aparicio M, De Precigout V, Reiffers J, et al. Multiple myeloma and AL amyloidosis in a renal transplant recipient. Nephron. 1989; 53:373-375.
26. Falkmer U, Jarhult J, Wersall P, Cavallin-Stahl E. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol. 2003;42:620-633.
27. Gregory WM, Richards MA, Malpas JS. Combined chemotherapy versus melphalan and prednisolone for treatment of myelomatosis. Lancet. 1992;339:1353-1354.
28. Myeloma Trialists' Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. J Clin Oncol. 1998;16:3832-3842.
29. Rosen LS, Gordon D, Kaminski M, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer. 2003;15:1735-1744.
30. Rego F, Alcantara P, Buinho F, et al. Autologous peripheral stem cell transplantation for multiple myeloma in a patient with a 10 year-old kidney transplant: case report and clinical issues. Transplant Proc. 2003;35:1102-1104.
31. Stachel D, Schmid I, Lang T, Haas RJ, Otte JB. Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance. Transpl Int. 2002;15:39-44.
32. Dey B, Sykes M, Spitzer TR. Outcomes of recipients of both bone marrow and solid organ transplants: a review. Medicine (Baltimore). 1998;77:355-369.
33. Perkins JL, Neglia JP, Ramsay NK, Davies SM. Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome. Bone Marrow Transplant. 2001;28:523-526.
34. Mahe B, Moreau P, Le Tortorec S, Hourmant M, Harousseau JL, Milpied N. Autologous bone marrow transplantation for cyclosporin-related lymphoma in a renal transplant patient. Bone Marrow Transplant. 1994;14:645-646.
35. Au WY, Lie AKW, Chan EC, et al. Treatment of postrenal transplantation lymphoproliferative disease manifesting as plasmacytoma with nonmyeloablative hematopoietic stem cell transplantation from the same kidney donor. Am J Hematol. 2003;74:283-286.